Filing Flows › Edwards Lifesciences (EW) › Net income
Edwards Lifesciences (EW) net income by quarter
Edwards Lifesciences' net income was $308M in Q3 2026 (third quarter 2026), +27% from Q2 2026. Over the last 7 quarters it ranged from $91.2M (Q4 2025) to $381M (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $308M | +27% | +6% |
| Q2 2026 | $242M | -36% | -27% |
| Q1 2026 | $381M | +317% | +6% |
| Q4 2025 | $91.2M | -69% | — |
| Q3 2025 | $291M | -13% | — |
| Q2 2025 | $333M | -7% | — |
| Q1 2025 | $358M | — | — |
Q3 2026 at a glance
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Questions
What is Edwards Lifesciences' net income?
Edwards Lifesciences' net income was $308M in Q3 2026 (third quarter 2026), +27% from Q2 2026.
How has Edwards Lifesciences' net income changed?
Over the last 7 quarters it ranged from $91.2M (Q4 2025) to $381M (Q1 2026).